0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Foods for Inborn Errors of Metabolism Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-22H8097
Home | Market Reports | Health| Nutrition
Global Medical Foods for Inborn Errors of Metabolism Market Insights Forecast to 2028
BUY CHAPTERS

Global Medical Foods for Inborn Errors of Metabolism Market Research Report 2024

Code: QYRE-Auto-22H8097
Report
June 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Foods for Inborn Errors of Metabolism Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Medical Foods for Inborn Errors of Metabolism Market

Medical Foods for Inborn Errors of Metabolism Market

Diet therapy is the traditional method of inborn errors of metabolism. Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids.
The global Medical Foods for Inborn Errors of Metabolism market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical Foods for Inborn Errors of Metabolism, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Foods for Inborn Errors of Metabolism.

Report Scope

The Medical Foods for Inborn Errors of Metabolism market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Foods for Inborn Errors of Metabolism market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Foods for Inborn Errors of Metabolism manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Medical Foods for Inborn Errors of Metabolism Market Report

Report Metric Details
Report Name Medical Foods for Inborn Errors of Metabolism Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Amino Acid
  • Glytactin with GMP
  • Amino Acid-Modified Infant Formula With Iron
  • Low Protein Food
  • Others
Segment by Application
  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Urea Cycle Disorders
  • Renal Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nestlé, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA, Galen Limited, PKU-MDMIL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medical Foods for Inborn Errors of Metabolism manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medical Foods for Inborn Errors of Metabolism in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Medical Foods for Inborn Errors of Metabolism Market report?

Ans: The main players in the Medical Foods for Inborn Errors of Metabolism Market are Nestlé, Abbott, Reckitt Benckiser Group, Ajinomoto, Solace Nutrition, Primus Pharmaceuticals, BioMarin Pharmaceutical, Danone SA, Galen Limited, PKU-MDMIL

What are the Application segmentation covered in the Medical Foods for Inborn Errors of Metabolism Market report?

Ans: The Applications covered in the Medical Foods for Inborn Errors of Metabolism Market report are Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Urea Cycle Disorders, Renal Disease, Others

What are the Type segmentation covered in the Medical Foods for Inborn Errors of Metabolism Market report?

Ans: The Types covered in the Medical Foods for Inborn Errors of Metabolism Market report are Amino Acid, Glytactin with GMP, Amino Acid-Modified Infant Formula With Iron, Low Protein Food, Others

1 Medical Foods for Inborn Errors of Metabolism Market Overview
1.1 Product Overview and Scope of Medical Foods for Inborn Errors of Metabolism
1.2 Medical Foods for Inborn Errors of Metabolism Segment by Type
1.2.1 Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Type (2024-2030)
1.2.2 Amino Acid
1.2.3 Glytactin with GMP
1.2.4 Amino Acid-Modified Infant Formula With Iron
1.2.5 Low Protein Food
1.2.6 Others
1.3 Medical Foods for Inborn Errors of Metabolism Segment by Application
1.3.1 Global Medical Foods for Inborn Errors of Metabolism Market Value by Application: (2024-2030)
1.3.2 Phenylketonuria (PKU)
1.3.3 Maple Syrup Urine Disease (MSUD)
1.3.4 Urea Cycle Disorders
1.3.5 Renal Disease
1.3.6 Others
1.4 Global Medical Foods for Inborn Errors of Metabolism Market Size Estimates and Forecasts
1.4.1 Global Medical Foods for Inborn Errors of Metabolism Revenue 2019-2030
1.4.2 Global Medical Foods for Inborn Errors of Metabolism Sales 2019-2030
1.4.3 Global Medical Foods for Inborn Errors of Metabolism Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Foods for Inborn Errors of Metabolism Market Competition by Manufacturers
2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Foods for Inborn Errors of Metabolism Average Price by Manufacturers (2019-2024)
2.4 Global Medical Foods for Inborn Errors of Metabolism Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Product Type & Application
2.7 Medical Foods for Inborn Errors of Metabolism Market Competitive Situation and Trends
2.7.1 Medical Foods for Inborn Errors of Metabolism Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Foods for Inborn Errors of Metabolism Players Market Share by Revenue
2.7.3 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario by Region
3.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Foods for Inborn Errors of Metabolism Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2019-2030
3.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2019-2024
3.2.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Region: 2025-2030
3.3 Global Medical Foods for Inborn Errors of Metabolism Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2019-2030
3.3.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2019-2024
3.3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2025-2030
3.4 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
3.4.1 North America Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2030)
3.4.3 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
3.5.1 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2030)
3.5.3 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
3.7.1 Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2030)
3.7.3 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2019-2030)
4.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2019-2024)
4.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2025-2030)
4.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2019-2030)
4.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2019-2030)
4.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2019-2024)
4.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2025-2030)
4.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2019-2030)
4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2019-2030)
5.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2019-2024)
5.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2025-2030)
5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2019-2030)
5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2019-2030)
5.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2019-2024)
5.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2025-2030)
5.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2019-2030)
5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nestlé
6.1.1 Nestlé Corporation Information
6.1.2 Nestlé Description and Business Overview
6.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.1.5 Nestlé Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Reckitt Benckiser Group
6.3.1 Reckitt Benckiser Group Corporation Information
6.3.2 Reckitt Benckiser Group Description and Business Overview
6.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.3.5 Reckitt Benckiser Group Recent Developments/Updates
6.4 Ajinomoto
6.4.1 Ajinomoto Corporation Information
6.4.2 Ajinomoto Description and Business Overview
6.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.4.5 Ajinomoto Recent Developments/Updates
6.5 Solace Nutrition
6.5.1 Solace Nutrition Corporation Information
6.5.2 Solace Nutrition Description and Business Overview
6.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.5.5 Solace Nutrition Recent Developments/Updates
6.6 Primus Pharmaceuticals
6.6.1 Primus Pharmaceuticals Corporation Information
6.6.2 Primus Pharmaceuticals Description and Business Overview
6.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.6.5 Primus Pharmaceuticals Recent Developments/Updates
6.7 BioMarin Pharmaceutical
6.6.1 BioMarin Pharmaceutical Corporation Information
6.6.2 BioMarin Pharmaceutical Description and Business Overview
6.6.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.7.5 BioMarin Pharmaceutical Recent Developments/Updates
6.8 Danone SA
6.8.1 Danone SA Corporation Information
6.8.2 Danone SA Description and Business Overview
6.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.8.5 Danone SA Recent Developments/Updates
6.9 Galen Limited
6.9.1 Galen Limited Corporation Information
6.9.2 Galen Limited Description and Business Overview
6.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.9.5 Galen Limited Recent Developments/Updates
6.10 PKU-MDMIL
6.10.1 PKU-MDMIL Corporation Information
6.10.2 PKU-MDMIL Description and Business Overview
6.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Portfolio
6.10.5 PKU-MDMIL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Foods for Inborn Errors of Metabolism Industry Chain Analysis
7.2 Medical Foods for Inborn Errors of Metabolism Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Foods for Inborn Errors of Metabolism Production Mode & Process
7.4 Medical Foods for Inborn Errors of Metabolism Sales and Marketing
7.4.1 Medical Foods for Inborn Errors of Metabolism Sales Channels
7.4.2 Medical Foods for Inborn Errors of Metabolism Distributors
7.5 Medical Foods for Inborn Errors of Metabolism Customers
8 Medical Foods for Inborn Errors of Metabolism Market Dynamics
8.1 Medical Foods for Inborn Errors of Metabolism Industry Trends
8.2 Medical Foods for Inborn Errors of Metabolism Market Drivers
8.3 Medical Foods for Inborn Errors of Metabolism Market Challenges
8.4 Medical Foods for Inborn Errors of Metabolism Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Medical Foods for Inborn Errors of Metabolism Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Medical Foods for Inborn Errors of Metabolism Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Medical Foods for Inborn Errors of Metabolism Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Medical Foods for Inborn Errors of Metabolism Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Medical Foods for Inborn Errors of Metabolism, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Product Type & Application
    Table 12. Global Key Manufacturers of Medical Foods for Inborn Errors of Metabolism, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Medical Foods for Inborn Errors of Metabolism by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Foods for Inborn Errors of Metabolism as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Medical Foods for Inborn Errors of Metabolism Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2019-2024) & (K Units)
    Table 18. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2019-2024)
    Table 19. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2025-2030) & (K Units)
    Table 20. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2025-2030)
    Table 21. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2019-2024)
    Table 23. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2025-2030)
    Table 25. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2024) & (K Units)
    Table 27. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2025-2030) & (K Units)
    Table 28. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Medical Foods for Inborn Errors of Metabolism Sales (K Units) by Type (2019-2024)
    Table 51. Global Medical Foods for Inborn Errors of Metabolism Sales (K Units) by Type (2025-2030)
    Table 52. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2019-2024)
    Table 53. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2025-2030)
    Table 54. Global Medical Foods for Inborn Errors of Metabolism Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Medical Foods for Inborn Errors of Metabolism Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2019-2024)
    Table 57. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2025-2030)
    Table 58. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Medical Foods for Inborn Errors of Metabolism Sales (K Units) by Application (2019-2024)
    Table 61. Global Medical Foods for Inborn Errors of Metabolism Sales (K Units) by Application (2025-2030)
    Table 62. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2019-2024)
    Table 63. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2025-2030)
    Table 64. Global Medical Foods for Inborn Errors of Metabolism Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Medical Foods for Inborn Errors of Metabolism Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2019-2024)
    Table 67. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2025-2030)
    Table 68. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Application (2025-2030)
    Table 70. Nestlé Corporation Information
    Table 71. Nestlé Description and Business Overview
    Table 72. Nestlé Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Nestlé Medical Foods for Inborn Errors of Metabolism Product
    Table 74. Nestlé Recent Developments/Updates
    Table 75. Abbott Corporation Information
    Table 76. Abbott Description and Business Overview
    Table 77. Abbott Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Abbott Medical Foods for Inborn Errors of Metabolism Product
    Table 79. Abbott Recent Developments/Updates
    Table 80. Reckitt Benckiser Group Corporation Information
    Table 81. Reckitt Benckiser Group Description and Business Overview
    Table 82. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product
    Table 84. Reckitt Benckiser Group Recent Developments/Updates
    Table 85. Ajinomoto Corporation Information
    Table 86. Ajinomoto Description and Business Overview
    Table 87. Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Ajinomoto Medical Foods for Inborn Errors of Metabolism Product
    Table 89. Ajinomoto Recent Developments/Updates
    Table 90. Solace Nutrition Corporation Information
    Table 91. Solace Nutrition Description and Business Overview
    Table 92. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product
    Table 94. Solace Nutrition Recent Developments/Updates
    Table 95. Primus Pharmaceuticals Corporation Information
    Table 96. Primus Pharmaceuticals Description and Business Overview
    Table 97. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product
    Table 99. Primus Pharmaceuticals Recent Developments/Updates
    Table 100. BioMarin Pharmaceutical Corporation Information
    Table 101. BioMarin Pharmaceutical Description and Business Overview
    Table 102. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product
    Table 104. BioMarin Pharmaceutical Recent Developments/Updates
    Table 105. Danone SA Corporation Information
    Table 106. Danone SA Description and Business Overview
    Table 107. Danone SA Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Danone SA Medical Foods for Inborn Errors of Metabolism Product
    Table 109. Danone SA Recent Developments/Updates
    Table 110. Galen Limited Corporation Information
    Table 111. Galen Limited Description and Business Overview
    Table 112. Galen Limited Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Galen Limited Medical Foods for Inborn Errors of Metabolism Product
    Table 114. Galen Limited Recent Developments/Updates
    Table 115. PKU-MDMIL Corporation Information
    Table 116. PKU-MDMIL Description and Business Overview
    Table 117. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product
    Table 119. PKU-MDMIL Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Medical Foods for Inborn Errors of Metabolism Distributors List
    Table 123. Medical Foods for Inborn Errors of Metabolism Customers List
    Table 124. Medical Foods for Inborn Errors of Metabolism Market Trends
    Table 125. Medical Foods for Inborn Errors of Metabolism Market Drivers
    Table 126. Medical Foods for Inborn Errors of Metabolism Market Challenges
    Table 127. Medical Foods for Inborn Errors of Metabolism Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Medical Foods for Inborn Errors of Metabolism
    Figure 2. Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Medical Foods for Inborn Errors of Metabolism Market Share by Type in 2023 & 2030
    Figure 4. Amino Acid Product Picture
    Figure 5. Glytactin with GMP Product Picture
    Figure 6. Amino Acid-Modified Infant Formula With Iron Product Picture
    Figure 7. Low Protein Food Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Medical Foods for Inborn Errors of Metabolism Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Medical Foods for Inborn Errors of Metabolism Market Share by Application in 2023 & 2030
    Figure 11. Phenylketonuria (PKU)
    Figure 12. Maple Syrup Urine Disease (MSUD)
    Figure 13. Urea Cycle Disorders
    Figure 14. Renal Disease
    Figure 15. Others
    Figure 16. Global Medical Foods for Inborn Errors of Metabolism Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Medical Foods for Inborn Errors of Metabolism Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Medical Foods for Inborn Errors of Metabolism Sales (2019-2030) & (K Units)
    Figure 19. Global Medical Foods for Inborn Errors of Metabolism Average Price (US$/Unit) & (2019-2030)
    Figure 20. Medical Foods for Inborn Errors of Metabolism Report Years Considered
    Figure 21. Medical Foods for Inborn Errors of Metabolism Sales Share by Manufacturers in 2023
    Figure 22. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Medical Foods for Inborn Errors of Metabolism Players: Market Share by Revenue in 2023
    Figure 24. Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Medical Foods for Inborn Errors of Metabolism Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2019-2030)
    Figure 27. North America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2019-2030)
    Figure 28. United States Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2019-2030)
    Figure 31. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2019-2030)
    Figure 39. China Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2019-2030)
    Figure 49. Latin America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. UAE Medical Foods for Inborn Errors of Metabolism Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of Medical Foods for Inborn Errors of Metabolism by Type (2019-2030)
    Figure 59. Global Revenue Market Share of Medical Foods for Inborn Errors of Metabolism by Type (2019-2030)
    Figure 60. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Type (2019-2030)
    Figure 61. Global Sales Market Share of Medical Foods for Inborn Errors of Metabolism by Application (2019-2030)
    Figure 62. Global Revenue Market Share of Medical Foods for Inborn Errors of Metabolism by Application (2019-2030)
    Figure 63. Global Medical Foods for Inborn Errors of Metabolism Price (US$/Unit) by Application (2019-2030)
    Figure 64. Medical Foods for Inborn Errors of Metabolism Value Chain
    Figure 65. Medical Foods for Inborn Errors of Metabolism Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS